Modulation of ionic currents in isolated canine and human jejunal circular smooth muscle cells by fluoxetine

G Farrugia1

  • 1Division of Gastroenterology and Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Gastroenterology
|May 1, 1996
PubMed
Abstract

Insights

Fluoxetine affects canine and human jejunal smooth muscle cells by altering potassium currents. These drug effects on muscle cells may explain common gastrointestinal side effects observed in patients.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Cell Physiology

Background:

  • Fluoxetine is a widely used antidepressant.
  • Gastrointestinal (GI) side effects are common with fluoxetine treatment.
  • The direct impact of fluoxetine on GI smooth muscle is not fully understood.

Purpose of the Study:

  • To investigate the effects of fluoxetine on isolated canine and human jejunal circular smooth muscle cells.
  • To elucidate the cellular mechanisms underlying fluoxetine's action on GI smooth muscle.
  • To explore potential links between fluoxetine's cellular effects and observed GI side effects.

Main Methods:

  • Utilized patch clamp electrophysiology to record ionic currents in smooth muscle cells.
  • Employed dual wavelength ratio techniques for cellular analysis.
  • Tested varying concentrations of fluoxetine on isolated canine and human jejunal cells.

Main Results:

  • Low concentrations of fluoxetine (1-10 µmol/L) reduced the delayed rectifier potassium current in canine cells.
  • Higher concentrations of fluoxetine (100 µmol/L - 1 mmol/L) increased outward currents, indicative of calcium-activated potassium channel activation, in canine cells.
  • Fluoxetine demonstrated similar, concentration-dependent effects on potassium currents in human jejunal cells.

Conclusions:

  • Fluoxetine exerts direct effects on canine and human jejunal smooth muscle cells.
  • The drug modulates potassium channel activity in a concentration-dependent manner.
  • These findings provide a cellular basis for the frequent gastrointestinal side effects associated with fluoxetine therapy.

Related Concept Videos

Enteric Nervous System: Regulation of GI Motor Activity01:11

Enteric Nervous System: Regulation of GI Motor Activity

The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
2.2K
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.6K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
2.0K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.4K
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.6K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
864